Your email has been successfully added to our mailing list.

×
0 0 -0.0132248219735503 -0.103763987792472 -0.0528992878942014 -0.0590030518819939 -0.069175991861648 -0.0752797558494405
Stock impact report

Clovis Oncology Announces 2019 Operating Results

Clovis Oncology, Inc. (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
Company Research Source: Business Wire
Rubraca® (rucaparib) net product revenue totaled $143.0M for 2019 and $39.3M for Q4 2019Net product revenue for 2019 up 50% over 2018 46% reduction in net cash utilized in 2H 2019 compared to 1H 2019 $296.7M in cash, cash equivalents and available for sale securities at December 31, 2019; continue to anticipate cash runway into 2H 2021Transaction in January 2020 reduced outstanding convertible debt at year-end 2019 by $123.4M Supplemental NDA for Rubraca in patients with BRCA1/2-mutant recurrent, metastatic castrate-resistant prostate cancer granted Priority Review by FDA with PDUFA date of May 15, 2020Lucitanib combination studies enrolling; initial data anticipated at medical meetings in 2020Acquired rights to FAP-2286, a radiopharmaceutical therapy targeting FAP; plan to submit an IND in 2H 2020 BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter and year ended December 31, 2019, and provided an update on Clovis’ clinic Show less Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CLVS alerts

from News Quantified
Opt-in for
CLVS alerts

from News Quantified